Efficacy of neoadjuvant chemotherapy combined with low-dose Apatinib in the treatment of triple negative breast cancer

Asian J Surg. 2023 Jul;46(7):2703-2704. doi: 10.1016/j.asjsur.2023.03.068. Epub 2023 Mar 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms* / drug therapy
  • Female
  • Humans
  • Neoadjuvant Therapy
  • Treatment Outcome
  • Triple Negative Breast Neoplasms* / drug therapy

Substances

  • apatinib
  • Antineoplastic Agents